PAI
Palo Alto Investors Portfolio holdings
AUM
$470M
This Quarter Return
+16.8%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$2.5B
AUM Growth
+$2.5B
(+7%)
Cap. Flow
-$121M
Cap. Flow
% of AUM
-4.85%
Top 10 Holdings %
Top 10 Hldgs %
71.22%
Holding
36
New
–
Increased
18
Reduced
2
Closed
–
Top Buys
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$46.3M |
| 2 |
Karyopharm Therapeutics
KPTI
|
$16.7M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$6.28M |
| 4 |
SAGE
Sage Therapeutics
SAGE
|
$2.22M |
| 5 |
Insmed
INSM
|
$1.82M |
Top Sells
| 1 |
ABMD
Abiomed Inc
ABMD
|
$187M |
| 2 |
Align Technology
ALGN
|
$11.7M |
Sector Composition
| 1 | Healthcare | 91.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABMD
1
DELISTED
Abiomed Inc
ABMD
| $364M | 14.55% | 890,309 -456,351 | -34% | -$187M |
|
2
BioMarin Pharmaceuticals
BMRN
$11.2B
| $240M | 9.6% | 2,549,431 +3,949 | +0.2% | +$372K |
|
|
CLVS
3
DELISTED
Clovis Oncology, Inc.
CLVS
| $226M | 9.04% | 4,974,007 +1,018,347 | +26% | +$46.3M |
|
4
United Therapeutics
UTHR
$13.8B
| $184M | 7.35% | 1,625,234 +2,603 | +0.2% | +$295K |
|
|
5
Insmed
INSM
$28.8B
| $171M | 6.84% | 7,236,583 +76,993 | +1% | +$1.82M |
|
|
ALXN
6
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $147M | 5.89% | 1,186,427 +50,582 | +4% | +$6.28M |
|
|
SAGE
7
DELISTED
Sage Therapeutics
SAGE
| $130M | 5.21% | 832,536 +14,205 | +2% | +$2.22M |
|
|
IMMU
8
DELISTED
Immunomedics Inc
IMMU
| $114M | 4.54% | 4,803,364 +7,356 | +0.2% | +$174K |
|
9
STAAR Surgical
STAA
$1.36B
| $109M | 4.36% | 3,521,565 +6,180 | +0.2% | +$192K |
|
10
Amicus Therapeutics
FOLD
$2.34B
| $96.4M | 3.85% | 6,168,347 +20,518 | +0.3% | +$320K |
|
|
EPZM
11
DELISTED
Epizyme, Inc
EPZM
| $93.6M | 3.74% | 6,906,158 +11,083 | +0.2% | +$150K |
|
|
12
Karyopharm Therapeutics
KPTI
$61.7M
| $79.2M | 3.17% | 4,663,324 +983,346 | +27% | +$16.7M |
|
13
Vanda Pharmaceuticals
VNDA
$279M
| $79.2M | 3.16% | 4,155,670 | – | – |
|
|
WMGI
14
DELISTED
Wright Medical Group Inc
WMGI
| $71.6M | 2.86% | 2,757,587 +5,293 | +0.2% | +$137K |
|
|
AMAG
15
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $65.1M | 2.6% | 3,340,806 | – | – |
|
|
16
Align Technology
ALGN
$10.3B
| $63.2M | 2.52% | 184,607 -34,100 | -16% | -$11.7M |
|
|
MNTA
17
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $37.5M | 1.5% | 1,833,532 +3,097 | +0.2% | +$63.3K |
|
|
AIMT
18
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $37.2M | 1.48% | 1,381,759 +25,245 | +2% | +$679K |
|
|
SHPG
19
DELISTED
Shire pic
SHPG
| $32.3M | 1.29% | 191,200 | – | – |
|
|
CELG
20
DELISTED
Celgene Corp
CELG
| $31.4M | 1.25% | 394,840 +15,700 | +4% | +$1.25M |
|
|
ALDR
21
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $29.3M | 1.17% | 1,853,101 +3,269 | +0.2% | +$51.7K |
|
22
Acadia Pharmaceuticals
ACAD
$4.38B
| $25.2M | 1.01% | 1,650,780 | – | – |
|
23
Exact Sciences
EXAS
$8.98B
| $18.7M | 0.75% | 313,320 +601 | +0.2% | +$35.9K |
|
24
Prothena Corp
PRTA
$441M
| $16.1M | 0.64% | 1,103,325 +1,987 | +0.2% | +$29K |
|
25
Gilead Sciences
GILD
$140B
| $12.5M | 0.5% | 175,900 | – | – |
|